Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule I - Condensed Statements of Cash Flow (Details)

v3.25.4
Schedule I - Condensed Statements of Cash Flow (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net income $ 22,744 $ 20,845 $ 34,566
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Deferred income taxes 5,064 (12,796) (4,680)
Gain from issuance of shares as payment of deferred consideration related to business acquisition 0 (2,681) 0
Share-based compensation 15,172 12,339 15,015
Other operating activities, net (981) 125 2,631
Changes in assets and liabilities:      
(Increase) decrease in other current assets (14,907) 13,893 (29,386)
Increase (decrease) in other current liabilities 8,280 (2,820) 990
Net cash provided by operating activities 192,585 221,858 136,094
Cash flows from financing activities:      
Common stock repurchased (27,964) (31,989) (33,694)
Dividends paid on common stock (13,622) (14,015) (14,272)
Dividends paid on redeemable preferred stock (5,750) (5,750) (5,750)
Payment of Ares Put Option 0 0 (9,808)
Net cash (used in) provided by financing activities (41,514) (56,004) 85,357
Cash and cash equivalents and restricted cash, beginning of year 292,408 241,421 316,769
Cash and cash equivalents and restricted cash, end of year 323,714 292,408 241,421
Supplementary cash flow information:      
Cash received for interest 10,750 9,485 7,944
Cash paid for interest 87,269 92,103 82,477
Cash paid for taxes 5,041 9,659 28,620
Supplementary noncash activities:      
Prepaid insurance premiums financed through notes payable 9,346 7,703 10,711
Issuance of shares as payment of deferred consideration related to business acquisition 0 22,319 0
Parent Company      
Cash flows from operating activities:      
Net income 22,744 20,845 34,369
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Equity income from subsidiaries (22,169) (11,047) (29,766)
Deferred income taxes (396) (3,320) 298
Amortization of deferred financing costs and debt discount 874 831 785
Gain from issuance of shares as payment of deferred consideration related to business acquisition 0 (2,681) 0
Share-based compensation 1,295 1,693 1,172
Fair value adjustment of financial liabilities (8,032) (11,338) (10,520)
Other operating activities, net 0 0 (116)
Changes in assets and liabilities:      
(Increase) decrease in other current assets (107) 24,679 4,856
Increase (decrease) in other current liabilities 1,622 1,193 (2,910)
Net cash provided by operating activities (4,169) 20,855 (1,832)
Cash flows from financing activities:      
Common stock repurchased (27,964) (31,989) (33,694)
Dividends paid on common stock (13,622) (14,015) (14,272)
Dividends paid on redeemable preferred stock (5,750) (5,750) (5,750)
Repayment of loans to subsidiaries 30,000 0 0
Loans from investees 0 30,000 0
Payment of Ares Put Option 0 0 (9,808)
Repayment of long-term debt (1,055) (1,184) (1,145)
Net cash (used in) provided by financing activities (18,391) (22,938) (64,669)
Net decrease in cash and cash equivalents and restricted cash (22,560) (2,083) (66,501)
Cash and cash equivalents and restricted cash, beginning of year 25,137 27,220 93,721
Cash and cash equivalents and restricted cash, end of year 2,577 25,137 27,220
Supplementary cash flow information:      
Cash received for interest 23,128 23,575 25,623
Cash paid for interest 24,738 23,084 23,089
Supplementary noncash activities:      
Prepaid insurance premiums financed through notes payable 1,024 1,101 671
Issuance of shares as payment of deferred consideration related to business acquisition $ 0 $ 22,319 $ 0